Study guide

7.4 Neonatal Heelstick & Newborn Metabolic Screening

NCCT National Certified Phlebotomy Technician NCPT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: NCPT Exam Overview, Eligibility & Study Strategy

1.1 Exam Facts, Format & Scoring 1.2 Eligibility Pathways, Application & Retake Policy 1.3 Blueprint Study Strategy & Credential Roadmap

2 Chapter 2: Infection Control & Safety (Domain 1 — 15%)

2.1 The Chain of Infection & Breaking Transmission 2.2 Hand Hygiene & Glove Use Standards 2.3 PPE Selection & Donning/Doffing Protocols 2.4 Sharps Safety & Safety-Device Activation 2.5 Isolation Precautions & Biohazard Spill Response 2.6 Cleaning & Disinfecting Equipment and Work Surfaces 2.7 OSHA Bloodborne Pathogens & Post-Exposure Management

3 Chapter 3: Equipment Selection (Domain 2A — 12 items)

3.1 Equipment Quality Verification & Allergy Alternatives 3.2 Venipuncture Equipment & Needle Anatomy 3.3 Winged Infusion Sets (Butterfly) & Syringe Systems 3.4 Capillary Equipment & Lancet Depth Selection 3.5 Bandaging Materials & Post-Collection Patient Care

4 Chapter 4: Patient & Site Preparation (Domain 2B — 13 items)

4.1 Patient Identification Standards 4.2 Requisition Review, Order Clarification & Documentation 4.3 Physiological Factors & Basal State Patient Prep 4.4 Patient Education & Therapeutic Communication 4.5 Venous Site Selection & Prohibited Sites 4.6 Antiseptic Selection & Tourniquet Application

5 Chapter 5: Routine Venipuncture Procedure (Domain 3 — 30%)

5.1 Prioritizing Collections: STAT, Timed & Routine 5.2 Routine Venipuncture: Preparation & Patient Assessment 5.3 Needle Insertion, Collection & Post-Puncture Care 5.4 CLSI Order of Draw & Tube Additive Mechanics 5.5 Fill Volumes, Inversions & Matching Tests to Tubes

6 Chapter 6: Special Patient Populations & Precautions

6.1 Precautions for Patients with Medical Conditions 6.2 Adapting Collection for Pediatric Patients 6.3 Geriatric, Dialysis & Other Difficult-Draw Populations

7 Chapter 7: Capillary & Special Collections

7.1 Capillary Blood Composition, Indications & Contraindications 7.2 Fingerstick Site Selection, Warming & Technique 7.3 CLSI GP42 Capillary Order of Draw & Blood Gas Collection 7.4 Neonatal Heelstick & Newborn Metabolic Screening 7.5 Blood Culture Collection Protocols & Timing 7.6 Therapeutic Drug Monitoring & Glucose Tolerance Testing 7.7 Point-of-Care Testing Procedures

8 Chapter 8: Specimen Handling, Processing & Non-Blood Specimens

8.1 Specimen Mixing & Mandatory Bedside Labeling 8.2 Assessing Specimen Suitability & Rejection Criteria 8.3 Temperature-, Light- & Time-Sensitive Specimen Handling 8.4 Specimen Processing: Centrifugation, Aliquoting & Storage 8.5 Non-Blood Specimen Collection & Patient Instruction 8.6 Processing Non-Blood Specimens & Routing to Laboratory Departments

9 Chapter 9: Collection Complications & Troubleshooting (Domain 4 — 15%)

9.1 Vasovagal Syncope: Recognition & Emergency Response 9.2 Seizures, Nausea, Petechiae & Allergic Reactions 9.3 Nerve Injury, Hematomas & Accidental Arterial Puncture 9.4 Technical Troubleshooting & the Two-Attempt Rule 9.5 Hemolysis & Hemoconcentration 9.6 IV Contamination & Analytical Interference

10 Chapter 10: Law, Ethics & Regulatory Standards (Domain 5 — 15%)

10.1 Civil Law, Torts, Negligence & Standard of Care 10.2 Patient Consent, the AHA Bill of Rights & Refusal 10.3 HIPAA Privacy Rule & Permitted Disclosures 10.4 Forensic Chain of Custody & Blood Alcohol Collection 10.5 Workplace Safety Regulation: OSHA, SDS, NFPA & Fire Response 10.6 CLIA ’88, Quality Assurance & Quality Control 10.7 Reportable Incidents, Risk Management & Error Disclosure

11 Chapter 11: Comprehensive Review & Clinical Practice Scenarios

11.1 Critical Order of Draw & Additive Reference Summary 11.2 Clinical Decision Scenarios & Troubleshooting Drills 11.3 Exam-Day Strategy & Professional Recertification

7.4 Neonatal Heelstick & Newborn Metabolic Screening

Key Takeaways Explain This Topic AI

Heelstick punctures are confined to the medial and lateral plantar surfaces of the heel, never the posterior curvature.

Maximum heelstick depth is 2.0 mm to avoid striking the calcaneus and causing osteomyelitis.

Heelsticks are used for infants under approximately one year, because fingersticks risk bone injury in small fingers.

Newborn screening blood spots must fill each printed circle completely from one side only, with no layering or double application.

Screening cards are air-dried horizontally at room temperature for approximately 3 hours and never stacked, heated, or placed in plastic.

Last updated: August 2026

  • 7.4 Neonatal Heelstick & Newborn Metabolic Screening
  • Neonatal Heelstick Protocols & Dermal Anatomy

In neonates and infants under 1 year of age (who have not begun walking), the heel is the primary anatomical site for capillary blood collection. Once a child begins walking and bearing weight, the heel develops a thick calloused epidermis and altered subcutaneous tissue, shifting the site of choice to the fingerpad. NEONATAL HEELSTICK ANATOMY

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ │
  • │ [TOES OF INFANT] │
  • │ (1) (2) (3) (4) (5) │
  • │ │ │ │
  • │ │ PLANTAR ARCH │ │
  • │ │ (PROHIBITED) │ │
  • │ │ │ │
  • │ v v │
  • │ ┌────────┬───────────────────┬────────┐ │
  • │ │ MEDIAL │ CENTRAL PLANTAR │ LATERAL│ │
  • │ │ BORDER │ (PROHIBITED) │ BORDER │ │
  • │ │ │ │ │ │
  • │ │ SAFE │ Nerves / Tendons │ SAFE │ │
  • │ │ ZONE │ Posterior Tibial │ ZONE │ │
  • │ │ ✓ │ X │ ✓ │ │
  • │ └────────┴───────────────────┴────────┘ │
  • │ │ │
  • │ v │
  • │ POSTERIOR CURVATURE │
  • │ (PROHIBITED - BONE!) │
  • │ │
  • └────────────────────────────────────────────────────────────────────────┘
  • Anatomical Safe Zones & Boundary Landmarks

To identify the safe zones on an infant's heel, the phlebotomist must visualize two anatomical guideline lines:

Medial Boundary Line: Drawn from the midpoint of the great toe (1st digit) posteriorly to the heel.

Lateral Boundary Line: Drawn from between the 4th and 5th toes posteriorly to the heel.

Safe Zone Rule: Punctures must only be performed on the medial plantar surface (medial to Line 1) or the lateral plantar surface (lateral to Line 2).

The Strict 2.0 mm Puncture Depth Standard

Caution

Maximum Heelstick Puncture Depth: 2.0 mm The maximum allowable depth for an infant heelstick is 2.0 mm for full-term infants and 0.85 mm to 1.5 mm for premature / low-birth-weight infants (< 1.0 kg).

Anatomical Rationale: In neonates, the average distance from the plantar skin surface to the calcaneus (heel bone) is only 2.4 mm to 3.0 mm (and less than 1.5 mm in premature neonates). Puncturing deeper than 2.0 mm risks the lancet striking the calcaneus periosteum, leading to:

Osteomyelitis: Severe bacterial infection and necrosis of the bone tissue.

Osteochondritis: Destructive inflammation of the heel bone cartilage.

Both conditions can cause permanent orthopedic deformity, systemic septic shock, or limb amputation.

Prohibited Heelstick Sites

Prohibited Heel Site Clinical & Anatomical Hazard

Posterior Curvature (Back of Heel) The calcaneus bone lies immediately beneath the skin surface at the posterior curvature (< 2.0 mm margin). Lancet contact with bone is almost guaranteed.

Plantar Arch of the Foot Contains the medial and lateral plantar nerves, flexor tendons, and branches of the posterior tibial artery. Puncture risks severe arterial hemorrhage and permanent motor/sensory nerve damage.

Previous Puncture Sites Introduces surface bacteria into healing tissue; high risk of localized abscess and hematoma formation.

Swollen, Edematous, or Bruised Areas Interstitial fluid and lysed red blood cells severely corrupt laboratory analyte measurements.

Fingers of Neonates / Infants Subcutaneous depth to bone in infant fingers is < 1.2 mm. Puncturing infant fingers is strictly prohibited due to extreme risk of bone penetration and digital gangrene.

Earlobe Punctures Prohibited by CLSI standards in all pediatric patients.

Newborn Metabolic Screening (NBS) Protocols

Newborn screening is a mandatory, state-legislated public health program designed to detect serious congenital, genetic, metabolic, and endocrine disorders before irreversible physical damage, mental disability, or death occurs. DISORDERS SCREENED ON NEWBORN FILTER CARDS

  • ┌───────────────────────┬────────────────────────────────────────────────┐
  • │ Screened Disorder │ Clinical Consequence if Undetected / Untreated │
  • ├───────────────────────┼────────────────────────────────────────────────┤
  • │ Phenylketonuria (PKU) │ Inability to metabolize phenylalanine; causes │
  • │ │ severe, irreversible cognitive impairment. │
  • ├───────────────────────┼────────────────────────────────────────────────┤
  • │ Congenital │ Thyroid hormone deficiency; causes stunted │
  • │ Hypothyroidism │ physical growth and permanent mental handicap. │
  • ├───────────────────────┼────────────────────────────────────────────────┤
  • │ Galactosemia │ Inability to metabolize galactose milk sugar; │
  • │ │ causes liver failure, cataracts, and death. │
  • ├───────────────────────┼────────────────────────────────────────────────┤
  • │ Sickle Cell Disease │ Hemoglobinopathy causing vaso-occlusive pain │
  • │ │ crises, splenic infarction, and acute stroke. │
  • ├───────────────────────┼────────────────────────────────────────────────┤
  • │ Cystic Fibrosis (CF) │ Exocrine gland dysfunction causing severe lung │
  • │ │ infections and pancreatic insufficiency. │
  • └───────────────────────┴────────────────────────────────────────────────┘
  • Collection Timing: The 24-to-48-Hour Feeding Rule

Mandatory Window: Newborn screening specimens must be collected between 24 and 48 hours after birth .

Dietary Requirement: For metabolic conditions like Phenylketonuria (PKU), the infant must have received protein and lactose feedings (breast milk or formula) for at least 24 hours prior to collection. If the infant has not consumed dietary protein, toxic metabolic byproducts (such as phenylalanine) will not have accumulated to detectable levels, producing a false-negative result .

Early Discharge Protocol: If an infant is discharged prior to 24 hours of life, a preliminary screen is collected before discharge, and the parents are instructed to return for a repeat screen within 7 to 14 days.

Guthrie Blood Spot Filter Paper Collection Technique

Newborn screening utilizes specialized absorbent filter paper cards (such as Whatman 903 or Ahlstrom 226 paper) imprinted with standardized printed circles. GUTHRIE CARD COLLECTION TECHNIQUE

  • ┌────────────────────────────────────────────────────────────────────────┐
  • │ │
  • │ CORRECT (Single Continuous Drop) INCORRECT (Layered Drops) │
  • │ ┌───────────────────┐ ┌───────────────────┐ │
  • │ │ ╭───────────╮ │ │ ╭─┬───┬───┬─╮ │ │
  • │ │ │ Uniform │ │ │ │1│ 2 │ 3 │4│ │ │
  • │ │ │ Saturation │ │ │ ╰─┴───┴───┴─╯ │ │
  • │ │ ╰───────────╯ │ │ │ │
  • │ └───────────────────┘ └───────────────────┘ │
  • │ Saturates completely Uneven specimen density │
  • │ through to back side. REJECTED by Public Health │
  • │ │
  • └────────────────────────────────────────────────────────────────────────┘

Aseptic Heel Prep: Warm heel for 3–5 min, cleanse medial/lateral plantar border with 70% IPA, and allow to air dry for 30 seconds.

Incision & First-Drop Discard: Puncture with a specialized infant lancet (≤ 2.0 mm depth) and wipe away the first drop of blood with sterile dry gauze .

Single Large Drop Formation: Allow a large, well-rounded drop of blood to accumulate on the heel surface.

Paper-to-Drop Contact: Gently touch the center of the printed circle on the filter paper directly to the blood drop. Do not press the filter paper directly against the infant's skin (skin contact transfers epidermal oils and crushes paper fibers).

Continuous Uniform Saturation: Allow the single drop to soak naturally into the paper by capillary absorption until the entire printed circle is filled and saturates completely through to the reverse side of the card .

Repeat for All Circles: Repeat the process for each printed circle on the card until all required circles are filled.

Specimen Rejection Criteria for Filter Paper Cards

Public health screening laboratories enforce strict specimen rejection criteria:

Layering: Adding multiple small drops to the same circle causes non-uniform blood concentration across the spot.

Insufficient Volume: Incomplete filling or failure of blood to soak completely through to the back side of the card.

Capillary Tube Transfer: Applying blood to filter cards using capillary tubes (especially heparinized or EDTA tubes) scratches the paper fibers and introduces chemical additives that invalidate tandem mass spectrometry testing.

Contamination: Touching printed circles with gloved or bare fingers, or contacting water, alcohol, formula, or antiseptic.

Drying Artifacts: Exposure to heat or stacking cards while damp.

Drying & Transport Standards

Drying Position: Cards must be placed horizontally (completely flat) on a clean, non-absorbent drying rack.

Ambient Environment: Air-dry at ambient room temperature ( 18°C to 25°C / 64°F to 77°F ) for 3 to 4 hours .

Prohibitions: Keep drying cards away from direct sunlight, heating vents, fans, and moisture. Never stack wet cards on top of one another.

Transport Window: Dried cards must be placed in authorized breathable paper transport envelopes and mailed to the state public health laboratory within 24 hours of collection .

Loading diagram... Neonatal Heelstick & Metabolic Screening Workflow